The NordICC Study: Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial.

OVERVIEW

Although some countries have implemented widespread colonoscopy screening, most European countries have not introduced it because of uncertainty regarding participation rates, procedure-related pain and discomfort, endoscopist performance, and effectiveness.

Title of publication

Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial.

AUTHORS

Bretthauer, M., Kaminski, M.F., Løberg, M., Zauber, A.G., Regula, J., Kuipers, E.J., Hernán, M.A., McFadden, E., Sunde, A., Kalager, M. and Dekker, E., Lansdorp-Vogelaar, I., Garborg, K., Rupinski, M., Spaander, M., Bugajski, M., Høie, O., Stefansson, T., Hoff, G., Adami, H-O., for the Nordic-European Initiative on Colorectal Cancer (NordICC) Study Group

PUBLICATION REFERENCE

JAMA Internal Medicine | Volume 176 | Issue 7 | 894-902 | 2016

MORE PUBLICATIONS FROM FRONTIER SCIENCE SCOTLAND

ALTTO | ESMO Open

ALTTO | ESMO Open

Final 10-year analysis of the ALTTO trial exploring dual anti-HER2 blockade with lapatinib + trastuzumab compared to trastuzumab alone.

read more
APHINITY | Journal of Clinical Oncology

APHINITY | Journal of Clinical Oncology

Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update

read more
OlympiA results in the subset of patients from Japan

OlympiA results in the subset of patients from Japan

The consistency of results between the subset of patients from Japan and the global OlympiA population supports the clinical benefit of adjuvant olaparib for patients with gBRCA1/2pv and HER2-negative, high-risk eBC in Japan after completion of local treatment and neoadjuvant or adjuvant CT.

read more